Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
VINORELBINE
Techno-Pharm Limited
10 Mg/Ml
Concentrate for Soln for Inf
2006-03-24
IRISH MEDICINES BOARD ACT 1995 MEDICINAL PRODUCTS(LICENSING AND SALE)REGULATIONS, 1998 (S.I. NO.142 OF 1998) PA0754/007/001 Case No: 2004475 The Irish Medicines Board in exercise of the powers conferred on it by the above mentioned Regulations hereby grants to TECHNO-PHARM LIMITED PHARMAPARK, CHAPELIZOD, DUBLIN 20, IRELAND an authorisation, subject to the provisions of the said Regulations, in respect of the product VINORELBINE "EBEWE" 10 MG/ML. CONCENTRATE FOR SOLUTION FOR INFUSION The particulars of which are set out in Part I and Part II of the attached Schedule. The authorisation is also subject to the general conditions as may be specified in the said Regulations as listed on the reverse of this document. This authorisation, unless previously revoked, shall continue in force from 24/03/2006 until 23/03/2011 . Signed on behalf of the Irish Medicines Board this ________________ A person authorised in that behalf by the said Board. IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 06/04/2006_ _CRN 2004475_ _page number: 1_ PART II SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Vinorelbine Ebewe 10mg/ml concentrate for solution for infusion 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each 1ml concentrate for solution for infusion contains 10 mg Vinorelbine (as tartrate) Each 5ml concentrate for solution for infusion contains 50 mg Vinorelbine (as tartrate) For Excipients see 6.1 3 PHARMACEUTICAL FORM Concentrate for solution for infusion Clear, colourless to pale yellow solution The diluted solution for infusion is a clear, colourless or pale yellow solution 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Non-small cell lung cancer Advanced breast cancer 4.2 POSOLOGY AND METHOD OF ADMI Read the complete document